Epsilogen

Epsilogen is a biotech company in Hammersmith, United Kingdom, founded in 2016. It has raised $65.8M across 3 rounds, most recently a $17.0M Extension Round in September 2024.

The world's leading pan-isotype therapeutic antibody company

Headquarters
Hammersmith
Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$65.8M
Last Round
$17.0M Extension RoundSep 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 6 investors for this company. The full record is or through the API.

About

Epsilogen is a clinical-stage company pioneering antibody therapeutics for oncology, with proprietary expertise in the discovery and development of IgE, IgA and IgG-based medicines. Evolved to treat parasitic infection, IgE can activate myeloid cells and T cells against tumours, while IgA acts through neutrophils; Epsilogen matches isotype to cancer type. Its lead candidate, MOv18 IgE, targets folate receptor alpha, completed a phase I trial in ovarian cancer, and is in a phase Ib study in platinum-resistant ovarian cancer. The company has also built platforms for bispecific IgE and IgEG antibodies.

Summary

It lists 11–50 employees. It has raised $65.8M in total across 3 rounds, most recently a $17.0M Extension Round in Sep 2024. Investors include Novartis Venture Fund, Epidarex Capital and British Patient Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Extension RoundSeries B ExpansionSep 2024
$17.0M

Sign up to see all 3 events

Funding: Series A through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Epsilogen on Indexed.vc
<a href="https://indexed.vc/companies/epsilogen"><img src="https://indexed.vc/api/badge/company/epsilogen" alt="Epsilogen on Indexed.vc" width="260" height="76" /></a>